- Home
- SUPV vs CRMD Comparison
SUPV vs CRMD Comparison
Compare SUPV & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPV
- CRMD
- Stock Information
- Founded
- SUPV 1887
- CRMD 2006
- Country
- SUPV Argentina
- CRMD United States
- Employees
- SUPV N/A
- CRMD N/A
- Industry
- SUPV Commercial Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- SUPV Finance
- CRMD Health Care
- Exchange
- SUPV Nasdaq
- CRMD Nasdaq
- Market Cap
- SUPV 905.2M
- CRMD 925.6M
- IPO Year
- SUPV 2016
- CRMD 2010
- Fundamental
- Price
- SUPV $5.69
- CRMD $13.12
- Analyst Decision
- SUPV Hold
- CRMD Strong Buy
- Analyst Count
- SUPV 3
- CRMD 8
- Target Price
- SUPV $17.00
- CRMD $17.57
- AVG Volume (30 Days)
- SUPV 1.8M
- CRMD 4.6M
- Earning Date
- SUPV 08-13-2025
- CRMD 10-29-2025
- Dividend Yield
- SUPV 3.16%
- CRMD N/A
- EPS Growth
- SUPV N/A
- CRMD N/A
- EPS
- SUPV 0.09
- CRMD 0.79
- Revenue
- SUPV $631,132,570.00
- CRMD $121,484,498.00
- Revenue This Year
- SUPV $29.13
- CRMD $404.81
- Revenue Next Year
- SUPV $31.07
- CRMD $56.11
- P/E Ratio
- SUPV $14.12
- CRMD $16.53
- Revenue Growth
- SUPV N/A
- CRMD 14970.29
- 52 Week Low
- SUPV $5.84
- CRMD $5.60
- 52 Week High
- SUPV $19.75
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- SUPV 24.66
- CRMD 50.22
- Support Level
- SUPV $5.84
- CRMD $12.73
- Resistance Level
- SUPV $6.40
- CRMD $13.83
- Average True Range (ATR)
- SUPV 0.53
- CRMD 0.74
- MACD
- SUPV -0.20
- CRMD -0.15
- Stochastic Oscillator
- SUPV 1.32
- CRMD 42.01
About SUPV Grupo Supervielle S.A. each Representing five Class B shares
Grupo Supervielle SA offers financial products & services. The company's segments include Personal and Business Banking, Corporate Banking, Bank Treasury, Consumer Finance, Insurance, and Asset Management and other services. The company provides services to individuals, small businesses, middle-market companies, and large corporates in Argentina. The company also offers mutual fund services.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.